// Company Overview //
| Stock Name | 國瑞置業有限公司 |
| Stock Code | 02329 |
| Company Full Name | 國瑞置業有限公司 |
| Industry | 地產 |
| Principal Activities | 主要于中國從事物業開發、一級土地建設及開發服務、物業投資以及物業管理及相關服務。 |
| Listing Date | 2014-07-07 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | No data |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市東城區崇文門外大街8號院1號樓哈德門廣場東塔 |
| Business Address (Hong Kong) | No data |
| Place of Incorporation | No data |
| Listing Method | No data |
| Listing Board | Main Board |
| Website | http://www.glorypty.com |
| Share Registrar | 香港中央證券登記有限公司 |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
// Offering Information //
| Prospectus Date | 2014-06-23 |
| Offer Price | HK$ 2.38 / shares |
| Total Funds Raised | HK$ 31,049,480 |
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
// First Day Performance
| First Day Close | Loading... |
| First Day Open | HK$ 2.32 |
| First Day Change | 5.04% |
| First Day Volume | 6447000.0 |
| First Day Turnover | 16288600.0 |
// Price Chart //
// Use of Proceeds
| Use of Proceeds | 1、約60%或約889.6百萬港元預期用于我們的物業開發項目,其中:
a.約40%或約593.1百萬港元預期用于開發北京國瑞中心、沈陽國瑞城四期、海闊天空國瑞城四及五期項目,包括高層及超高層地標性甲級寫字樓;
b.其余20%或約296.5百萬港元預期用于我們的其他物業開發項目,包括開發鄭州國瑞城六期及永清國瑞城四期;
2、約30%或約444.8百萬港元預期用于未來在我們目前經營所在城市和目標城市,特別是珠江三角洲,物色和收購合適的地塊作為我們的土地儲備;
3、其余10%或約148.3百萬港元將作我們的一般企業及營運資金用途。
|
// Underwriting Syndicate //
联席账簿管理人 (2)
中银国际亚洲有限公司
招商证券(香港)有限公司
联席牵头经办人 (2)
中银国际亚洲有限公司
招商证券(香港)有限公司
// Cornerstone Investors //
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
| 1 |
Best Class Industrial Limited |
143,540,180 HKD |
— |
1.37% |
— |
6 months |
2015-01-07 |
| 2 |
北京市第五建筑工程集团有限公司 |
233,368,520 HKD |
— |
2.22% |
— |
6 months |
2015-01-07 |
| 3 |
中国生物制药有限公司 |
287,080,360 HKD |
— |
2.73% |
— |
6 months |
2015-01-07 |
// Directors & Management //
| Chairman | 張章筍 |
| Company Secretary | 陳樂彤 |
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 張章筍(76.71%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.